Stay updated on Venetoclax and Novel Agents in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax and Novel Agents in AML Clinical Trial page.

Latest updates to the Venetoclax and Novel Agents in AML Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now displays an updated ClinicalTrials.gov interface revision version (v3.5.3 instead of v3.5.2). This represents a site/version update rather than a change to the underlying study record.SummaryDifference0.1%

- Check21 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check50 days agoChange DetectedThe history adds a new site revision entry (v3.5.0) and removes an older entry (v3.4.3). This reflects a software update and does not alter trial data or content.SummaryDifference0.1%

- Check57 days agoChange DetectedAdded revision v3.4.3 and removed revision v3.4.2 from the history.SummaryDifference0.1%

- Check86 days agoChange DetectedThe history now shows Revision: v3.4.2 and removes Revision: v3.4.1 from the current view.SummaryDifference0.1%

- Check93 days agoChange DetectedThe history record now shows a new revision entry v3.4.1, replacing the previous revision v3.4.0.SummaryDifference0.1%

Stay in the know with updates to Venetoclax and Novel Agents in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax and Novel Agents in AML Clinical Trial page.